Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions
Drug repurposing or repositioning has been well-known to refer to the therapeutic applications of a drug for another indication other than it was originally approved for. Repurposing non-oncology small-molecule drugs has been increasingly becoming an attractive approach to improve cancer therapy, wi...
Saved in:
Main Authors: | Leilei Fu (Author), Wenke Jin (Author), Jiahui Zhang (Author), Lingjuan Zhu (Author), Jia Lu (Author), Yongqi Zhen (Author), Lan Zhang (Author), Liang Ouyang (Author), Bo Liu (Author), Haiyang Yu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
by: Xin Jin, et al.
Published: (2024) -
Inhibiting Cytoprotective Autophagy in Cancer Therapy: An Update on Pharmacological Small-Molecule Compounds
by: Lijuan Zhang, et al.
Published: (2022) -
Direct Reprogramming of Mouse Fibroblasts to Neural Stem Cells by Small Molecules
by: Yan-Chuang Han, et al.
Published: (2016) -
Screening Repurposed Antiviral Small Molecules as Antimycobacterial Compounds by a Lux-Based phoP Promoter-Reporter Platform
by: Li Zhu, et al.
Published: (2022) -
"Hard" Drug Repurposing for Precision Oncology: The Missing Link?
by: Pan Pantziarka, et al.
Published: (2018)